// App-Quantinova.ai

AB0196 (2022) : ABATACEPT VERSUS HYDROXYCHLOROQUINE IN PALINDROMIC RHEUMATISM: A MULTICENTER RANDOMIZED CLINICAL TRIAL (PALABA STUDY): TRIAL DESIGN AND PATIENTS CHARACTERISTICS

Researchers

Presenter

  • B. Frade-Sosa

Principal Investigators

  • R. Morl

  • L. Tobalina

  • C. Perez-Garcia

  • I. Haro

  • R. Sanmart

Medical Centers

  • Hospital Clinic de Barcelona, Arthritis Unit. Department of Rheumatology, Barcelona, Spain

  • Hospital Dos de Maig, Rheumatology, Barcelona, Spain

  • Institute of Advanced Chemistry of Catalonia (IQAC-CSIC),, Unit of Synthesis and Biomedical Applications of Peptides., Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Abatacept

  • SC-125

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

  • Controlled

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved